Cancer treatment sector surges, Shuanglu Pharmaceutical hits the daily limit

MaticHoleFiller · 2026-03-27T15:23:36+00:00

As of March 27th at 10:45, the anti-cancer treatment sector continues to rise, with Shuanglu Pharmaceutical hitting the daily limit. Shares such as Shute Shen, Xinli Tai, Kelun Pharmaceutical, and Hengrui Medicine performed well. Investment should be cautious; this content is for reference only.

MaticHoleFiller

2026-03-27 15:23:36

Abstract generation in progress

March 27 news, as of 10:45, the anti-cancer and cancer treatment sector has surged, with Shuanglu Pharmaceutical hitting the daily limit, and stocks such as Shutai Shen, Xinlitai, Kelun Pharmaceutical, and Heng Rui Medicine leading in gains.

Disclaimer: The market has risks, and investments must be cautious. This article is automatically published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have any questions, please contact biz@staff.sina.com.cn.

Massive news, precise interpretation, all in the Sina Finance APP

Editor: Xiao Lang Kuaibao

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes